PTGS1 and cancer: Aspirin, inhibiting cyclooxygenase-1 (COX-1) –derived thromboxane A2 (TXA2) synthesis in platelets (and thus platelet aggregation and degranulation) was the first anti-platelet drug used to combat cancer metastasis [15].